Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EG-1962 vs Oral Nimodipine in Aneurysmal Subarachnoid Hemorrhage
NCT02790632Phase 3Terminated
- Sponsor
- Edge Therapeutics
- Start
- Jul 2016
- Primary completion
- Jun 2018
- Modality
- Nanoparticles, Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of EG-1962 in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Edge Therapeutics. Started Jul 2016; status: terminated.
02
Drugs
EG-1962
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT02790632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02790632.